Gary K. Lee
CIK 1907345 · Chief Scientific Officer · last filed 2026-11-12
Gary K. Lee is a Chief Scientific Officer who has filed 15 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider sold $2.1K of LYEL on Nov 12, 2026. Across all open-market trades the lifetime net is −$91.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $219.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LYEL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA 94080
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | Chief Scientific Officer | 16,091 | $13.62 | $219.2K | -$91.9K | 15 | 2026-11-12 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-11-12 | LYEL | Sell (S) | −129 | -$2.1K | EDGAR |
| 2026-08-25 | LYEL | Sell (S) | −1,457 | -$22.6K | EDGAR |
| 2026-08-11 | LYEL | Sell (S) | −131 | -$1.9K | EDGAR |
| 2026-06-15 | LYEL | Sell (S) | −130 | -$2.5K | EDGAR |
| 2026-02-12 | LYEL | Sell (S) | −1,671 | -$39.1K | EDGAR |
| 2026-02-11 | LYEL | Mixed | +3,853 | -$3.4K | EDGAR |
| 2025-11-12 | LYEL | Sell (S) | −138 | -$2.2K | EDGAR |
| 2025-10-29 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2025-08-22 | LYEL | Mixed | +6,547 | -$15.3K | EDGAR |
| 2025-08-13 | LYEL | Sell (S) | −267 | -$2.8K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).